Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

Medicenna Therapeutics Selects Kalon Biotherapeutics To Manufacture New Cancer Drug

Jun 26, 2014

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

Rentschler Invests in New Stainless-Steel Bioreactors

Jun 26, 2014

Rentschler plans to build two stainless-steel bioreactors to target market supply.

SGS Introduces the Cobas 6000 Analyzer Series

Jun 26, 2014

SGS introduces the Cobas 6000 Analyzer System for its France-based laboratory.

Frontage Labs Plans Expansion of CMC Facility

Jun 26, 2014

Frontage Labs will expand its CMC facility in Exton, PA.

Jones Packaging Invests in New Solid Dose Vial Line

Jun 26, 2014

Jones Packaging introduces a new solid dose vial line in its Toronto facility.

More than 430 New Medicines in Development for Chronic Diseases

Jun 26, 2014

PhRMA announced 430 new medicines in development to treat chronic diseases affecting older Americans.

National Bioscience Report Reveals Positive Trends for Bioscience Industry

Jun 25, 2014

According to the National Bioscience Report, the US bioscience industry is on course for continued growth.

NIH launches 3D Print Exchange for Researchers

Jun 24, 2014

NIH launched 3D Print Exchange, a public website promoting health and science applications of 3D printing.

Big Pharma Industry Shrinks While Biotech Booms

Jun 18, 2014

Big pharma employment dropped by 3% between 2003 and 2013, according to a new jobs report published by EP Vantage.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here